ARK Genomic Revolution Multi-Sector ETF (ARKG)

Add to Watchlists
Create an Alert
31.17 -1.08  -3.35% NYSE Arca Aug 23, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -8.51% -8.40% -4.28% 96
3M 2.70% 2.77% 0.26% 20
6M 5.77% 5.80% -3.78% 2
YTD 29.98% 29.70% 7.81% 1
1Y -0.63% -0.38% -6.75% 17
3Y 18.98% 19.08% 7.30% 3
5Y -- -- 7.55% --
10Y -- -- 14.13% --
15Y -- -- 10.69% --
20Y -- -- 9.75% --
As of Aug. 23, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.21% 0.21% 0.00%
Stock 99.79% 99.79% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of June 30, 2019

Region Exposure

Americas 87.13%
North America 87.13%
Latin America 0.00%
Greater Europe 12.87%
United Kingdom 0.00%
Europe Developed 9.55%
Europe Emerging 0.00%
Africa/Middle East 3.33%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of June 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 92.73%
Industrials 0.00%
Real Estate 0.00%
Technology 7.27%
Utilities 0.00%
As of June 30, 2019

Stock Market Capitalization

Giant 3.03%
Large 16.39%
Medium 11.77%
Small 52.03%
Micro 16.77%
As of June 30, 2019

Stock Style Exposure

Large Cap Value 3.28%
Large Cap Blend 1.12%
Large Cap Growth 16.30%
Mid Cap Value 0.00%
Mid Cap Blend 0.00%
Mid Cap Growth 11.02%
Small Cap Value 0.07%
Small Cap Blend 22.56%
Small Cap Growth 45.65%
As of June 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
ILMN Illumina Inc 11.29% 279.44 -3.17%
NVTA Invitae Corp 9.89% 24.00 -1.76%
NTLA Intellia Therapeutics Inc 6.71% 15.77 -6.41%
CRSP CRISPR Therapeutics AG 6.45% 46.63 -4.56%
EDIT Editas Medicine Inc 5.87% 24.06 -4.86%
VCYT Veracyte Inc 4.81% 24.66 -2.53%
IOVA Iovance Biotherapeutics Inc 4.41% 19.60 +0.46%
TDOC Teladoc Health Inc 4.23% 56.05 -6.24%
NSTG NanoString Technologies Inc 4.10% 23.35 -7.63%
CLLS Cellectis SA ADR 3.08% 12.10 -3.28%
As of June 30, 2019
Advertisement

One Page Reports

Basic Info

Style
Equity Style Small Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Unaligned
Fund Owner Firm Name ARK ETF Trust
Benchmark Index
NASDAQ Health Care GR EUR
100.0%

Manager Info

Name Tenure
Catherine Wood 4.76 yrs

Net Fund Flows

1M 17.02M
3M 12.33M
6M 82.00M
YTD 100.14M
1Y 185.94M
3Y 390.07M
5Y --
10Y --
As of July 31, 2019

Risk Info

Beta (5Y) 1.754
Max Drawdown (All) 37.44%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.839
30-Day Rolling Volatility 32.98%
Daily Value at Risk (VaR) 1% (All) 5.10%
Monthly Value at Risk (VaR) 1% (All) 19.75%

Fundamentals

Dividend Yield TTM (8-23-19) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 11.71
Weighted Average Price to Book Ratio 5.707
Weighted Median ROE -23.30%
Weighted Median ROA -23.19%
Forecasted Dividend Yield 0.15%
Forecasted PE Ratio 28.04
Forecasted Price to Sales Ratio 3.003
Forecasted Price to Book Ratio 4.617
Number of Holdings 37
As of June 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 12.69%
Forecasted Book Value Growth -6.06%
Forecasted Cash Flow Growth 36.66%
Forecasted Earnings Growth 48.00%
Forecasted Revenue Growth 16.62%
As of June 30, 2019

Comparables

Edit

Attributes

Key Dates
Inception Date 10/30/2014
Termination Date
Last Annual Report Date 7/31/2018
Last Prospectus Date 11/30/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

Excel Add-In Codes

  • Name: =YCI("ARKG","name")
  • Broad Asset Class: =YCI("ARKG", "broad_asset_class")
  • Broad Category: =YCI("ARKG", "broad_category_group")
  • Prospectus Objective: =YCI("ARKG", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.